Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Gujarat Kidney And Super Speciality 3-Year ROIIC %?
Gujarat Kidney And Super SpecialityNSE:GKSL +0.71%18 3-Year ROIIC % is 5.73 as of Mar. 2026, which is at its 10-year median of 5.73. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 620 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks better than 54.84% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Gujarat Kidney And Super Speciality's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 5.73%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
NSE:GKSL's 3-Year ROIIC % is ranked better than 54.84% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.37
vs NSE:GKSL: 5.73
Gujarat Kidney And Super Speciality (NSE:GKSL) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Gujarat Kidney And Super Speciality 3-Year ROIIC % Related Terms
Gujarat Kidney And Super Speciality 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality 3-Year ROIIC % Chart
Gujarat Kidney And Super Speciality Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
3-Year ROIIC %
0.00
0.00
0.00
5.73
Gujarat Kidney And Super Speciality Quarterly Data
NSE:GKSL vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Kidney And Super Speciality 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Gujarat Kidney And Super Speciality's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Gujarat Kidney And Super Speciality (NSE:GKSL) has a 3-Year ROIIC % of 5.73 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is near median its historical median of 5.73. Over the past decade, Gujarat Kidney And Super Speciality's 3-Year ROIIC % has ranged from 5.73 to 5.73. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #280 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 45.2%.
Is Gujarat Kidney And Super Speciality's 3-Year ROIIC % too high?
Gujarat Kidney And Super Speciality's current 3-Year ROIIC % of 5.73 is near median its 10-year median of 5.73. Over the past 10 years, this metric has ranged from a low of 5.73 to a high of 5.73. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.37. Gujarat Kidney And Super Speciality's value of 5.73 is 70% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #280 out of 620 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #280 out of 620 companies for 3-Year ROIIC %. This puts Gujarat Kidney And Super Speciality in the upper half of its industry. The industry median 3-Year ROIIC % is 3.37. Gujarat Kidney And Super Speciality's value of 5.73 is 70% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own 3-Year ROIIC % has ranged from 5.73 to 5.73 over the past decade. While the company's 10-year median is 5.73 vs. the industry median of 3.37, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.37, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current 3-Year ROIIC % of 5.73 is 70% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current 3-Year ROIIC % is 5.73, which is near median its own 10-year median of 5.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current 3-Year ROIIC % of 5.73. The current 3-Year ROIIC % is 5.73, which is near median its 10-year median of 5.73 and 70% above the Healthcare Providers & Services industry median of 3.37. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current 3-Year ROIIC % is 5.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gujarat Kidney And Super Speciality Business Description
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score
Get the complete analysis for NSE:GKSL
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GKSL has been successfully added to your 
